SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mudcat who wrote (24307)8/9/1998 7:27:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
Speaking of doubling by the end of the year, EquityAnalysis.com (http://www.equityanalysis.com/bioarchive.htm chose LGND as its Biotech pick for July. They have a 1 year target of $25 and a two year target of $40.



To: Mudcat who wrote (24307)8/9/1998 11:25:00 PM
From: RXGOLF  Respond to of 32384
 
<<Greg, I think the warrents are a bargain at this price. I bought a few thousand shares on Thursday and Friday. I expect them to double or more by year end.>>

Thanks for the insight! This seems to be what several think is the best play at this point. Do the warrants trade under LGNDW, and do I buy and sell them just like the shares??

Thanks for the advice,
Greg


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News